Date published: 2026-7-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

GalNAc-T14 Inhibitors

GalNAc-T14 inhibitors belong to a specialized chemical class designed to modulate the activity of the enzyme N-acetylgalactosaminyltransferase 14 (GalNAc-T14). GalNAc-T14 is a member of the glycosyltransferase family of enzymes, playing a crucial role in the intricate process of protein glycosylation. Glycosylation is a post-translational modification where sugar molecules are attached to proteins, influencing their structure and function. Specifically, GalNAc-T14 is responsible for catalyzing the transfer of N-acetylgalactosamine (GalNAc) residues onto target proteins, a pivotal step in the synthesis of mucin-type O-glycans. GalNAc-T14 is of particular interest in understanding and manipulating cellular glycosylation patterns. By selectively targeting this enzyme, GalNAc-T14 inhibitors aim to modulate the glycosylation profile of proteins, potentially unveiling insights into the functional consequences of altered glycan structures. This class of compounds serves as valuable tools for researchers exploring the intricacies of cellular processes influenced by protein glycosylation. Understanding the specific roles of GalNAc-T14 and the consequences of its inhibition may pave the way for a deeper comprehension of cellular signaling, protein interactions, and various physiological phenomena where glycosylation is implicated. As researchers delve into the molecular mechanisms governed by GalNAc-T14 inhibitors, they contribute to the expanding field of chemical biology and advance our knowledge of the complex interplay between enzymes and their substrates in cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside

3554-93-6sc-203427
sc-203427A
100 mg
1 g
$350.00
$3184.00
2
(0)

Inhibitor of O-glycosylation by mimicking the natural substrate and competitively inhibiting the enzyme.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Blocks N-linked glycosylation, indirectly affecting O-glycosylation pathways by altering glycosylation balance.

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

Inhibits Golgi α-mannosidase II, indirectly affecting glycosylation processing which could impact GalNAc-T14 substrate availability.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

Inhibitor of glucosidase, which alters glycoprotein folding and could indirectly affect O-glycosylation.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

Another glucosidase inhibitor that may lead to alterations in glycoprotein processing and O-glycosylation.

Deoxymannojirimycin hydrochloride

84444-90-6sc-201360
sc-201360A
1 mg
5 mg
$93.00
$239.00
2
(0)

Inhibits mannosidase, potentially affecting glycoprotein processing pathways related to O-glycosylation.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$135.00
$540.00
$1025.00
$6248.00
25
(2)

Mannosidase inhibitor which could indirectly alter glycoprotein maturation, affecting O-glycosylation indirectly.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi apparatus function, which in turn can affect various glycosylation pathways, including the one mediated by GalNAc-T14.

Celgosivir

121104-96-9sc-488385
sc-488385A
sc-488385B
5 mg
25 mg
100 mg
$525.00
$902.00
$2700.00
(0)

Prodrug of castanospermine which inhibits glucosidase, and could indirectly impact O-glycosylation.

Decylubiquinone

55486-00-5sc-358659
sc-358659A
10 mg
50 mg
$70.00
$269.00
10
(2)

Ubiquinone analog that disrupts electron transport and could indirectly influence cellular processes including glycosylation.